Abstract
Background and Purpose: To evaluate the significance of multidrug-resistant Acinetobacter baumannii (MDRAB)-related ventilator-associated pneumonia at a medical center in southern Taiwan. Methods: We retrospectively reviewed the medical records of patients with MDRAB isolated from sputum and described the characteristics of these patients. Patients were divided into 2 groups according to their clinical pulmonary infection scores (CPIS), and their host factors and outcomes compared. Results: In the patient group with significant MDRAB-related lung infection, Acute Physiology and Chronic Health Evaluation II scores were significantly higher than in those patients with lower CPIS scores (<6). However, the clinical outcomes, including the duration of hospitalization after isolation of MDRAB and mortality rate, were not different. Conclusion: Our investigation showed that significant lung infections with MDRAB isolation did not result in prolonged hospitalization or increased mortality. The initial clinical severity of the group with significant MDRAB-related lung infection was significantly greater than in the other. We propose that MDRAB-related pneumonia should be regarded as a signal of the clinical severity of the patient rather than as a prognostic factor.
Original language | English |
---|---|
Pages (from-to) | 401-405 |
Number of pages | 5 |
Journal | Journal of Microbiology, Immunology and Infection |
Volume | 40 |
Issue number | 5 |
Publication status | Published - Oct 2007 |
Externally published | Yes |
Keywords
- Acinetobacter baumannii
- Drug resistance, multiple, bacterial
- Pneumonia, ventilator-associated
- Sulbactam
ASJC Scopus subject areas
- General Immunology and Microbiology
- Microbiology (medical)
- Infectious Diseases
- Immunology and Allergy